PSMA7 and mixed phenotype acute leukemia: Similarly, in patients LCL465 [mixed-phenotype acute leukemia (MPAL)] and LCL230, a clear separation between the diagnosis and relapse clusters was demonstrated (p < 0.05), and the relapse cluster was composed of MLP-like and GMP-like HSPC subpopulations, already present at diagnosis.